当前位置:首页 - 行情中心 - 东宝生物(300239) - 财务分析 - 现金流量表

东宝生物

(300239)

  

流通市值:28.96亿  总市值:29.15亿
流通股本:5.90亿   总股本:5.94亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金321,837,592.74164,105,643.42668,879,098.4489,226,887.66
  收到的税费返还2,156,922.18204,814.455,389,635.263,132,961.81
  收到其他与经营活动有关的现金7,401,793.98482,985.8716,490,205.8613,254,958.02
  经营活动现金流入小计331,396,308.9164,793,443.74690,758,939.52505,614,807.49
  购买商品、接受劳务支付的现金154,283,513.591,284,635.14349,225,621.94277,542,636.41
  支付给职工以及为职工支付的现金86,700,810.7143,063,430.43163,134,062.76120,249,353
  支付的各项税费25,791,471.143,990,542.8153,508,901.5234,066,074.39
  支付其他与经营活动有关的现金10,099,313.185,521,561.9518,966,240.6812,339,049.97
  经营活动现金流出小计276,875,108.53143,860,170.33584,834,826.9444,197,113.77
  经营活动产生的现金流量净额54,521,200.3720,933,273.41105,924,112.6261,417,693.72
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额--151,315118,103.67
  收到的其他与投资活动有关的现金2,050,422,920.16946,277,106.183,965,883,879.492,909,427,989.54
  投资活动现金流入小计2,050,422,920.16946,277,106.183,966,035,194.492,909,546,093.21
  购建固定资产、无形资产和其他长期资产支付的现金88,347,267.9547,160,545.1379,272,782.846,923,643.06
  支付其他与投资活动有关的现金2,048,000,000944,080,3303,960,000,0002,905,000,000
  投资活动现金流出小计2,136,347,267.95991,240,875.134,039,272,782.82,951,923,643.06
  投资活动产生的现金流量净额-85,924,347.79-44,963,768.95-73,237,588.31-42,377,549.85
三、筹资活动产生的现金流量:
  取得借款收到的现金--54,400,00054,400,000
  收到其他与筹资活动有关的现金--113,104.02113,104.02
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--54,513,104.0254,513,104.02
  偿还债务支付的现金2,270,000-52,096,70049,326,700
  分配股利、利润或偿付利息支付的现金7,436,731.69219,716.2518,278,322.0917,963,157.79
  支付其他与筹资活动有关的现金--56,114,846.3656,114,846.36
  筹资活动现金流出小计9,706,731.69219,716.25126,489,868.45123,404,704.15
  筹资活动产生的现金流量净额-9,706,731.69-219,716.25-71,976,764.43-68,891,600.13
四、汇率变动对现金及现金等价物的影响4,166.08-4,320.24-50,573.03-50,162.06
五、现金及现金等价物净增加额-41,105,713.03-24,254,532.03-39,340,813.15-49,901,618.32
  加:期初现金及现金等价物余额458,774,068.33458,774,068.33498,114,881.48498,114,881.48
  期末现金及现金等价物余额417,668,355.3434,519,536.3458,774,068.33448,213,263.16
补充资料:
  净利润37,404,024.43-54,335,408.98-
  资产减值准备1,640,693.75-16,003,053.1-
  固定资产和投资性房地产折旧45,180,234.93-89,594,869.54-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧45,180,234.93-89,594,869.54-
  无形资产摊销3,364,324.01-7,664,276.58-
  长期待摊费用摊销329,909.29-1,101,108.68-
  处置固定资产、无形资产和其他长期资产的损失-46,679.48-93,367.15-
  固定资产报废损失18,042.48-273,368.91-
  财务费用716,623.2-2,811,818.65-
  投资损失811,232.23-2,861,860.37-
  递延所得税-2,370,484.36-191,508.36-
  其中:递延所得税资产减少-1,416,325.2--5,180,434.47-
    递延所得税负债增加-954,159.16-5,371,942.83-
  存货的减少2,374,596.43--59,982,098.27-
  经营性应收项目的减少-46,028,378.1-71,755,603.95-
  经营性应付项目的增加8,282,087.74--82,520,985.3-
  其他2,844,973.82-1,740,951.92-
  现金的期末余额417,668,355.3-458,774,068.33-
  减:现金的期初余额458,774,068.33-498,114,881.48-
  现金及现金等价物的净增加额-41,105,713.03--39,340,813.15-
公告日期2026-08-242026-04-242026-03-302025-10-29
审计意见(境内)标准无保留意见
TOP↑